Walleye Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$731K Buy
10,271
+6,867
+202% +$542K ﹤0.01% 2358
2025
Q4
$279K Sell
3,404
-204,038
-98% -$15.9M ﹤0.01% 3361
2025
Q3
$15.6M Buy
207,442
+188,207
+978% +$14M 0.06% 348
2025
Q2
$1.42M Buy
19,235
+18,861
+5,043% +$1.31M 0.01% 1770
2025
Q1
$30.2K Sell
374
-7,848
-95% -$674K ﹤0.01% 3951
2024
Q4
$643K Buy
8,222
+6,255
+318% +$532K ﹤0.01% 2773
2024
Q3
$185K Sell
1,967
-2,527
-56% -$212K ﹤0.01% 4058
2024
Q2
$350K Buy
4,494
+4,424
+6,320% +$361K ﹤0.01% 3839
2024
Q1
$6.36K Buy
+70
New +$5.83K ﹤0.01% 5121

Other funds holding GEHC

Walleye Capital's GEHC Position: Q1 2026 in Review

Walleye Capital increased its GE HealthCare (GEHC) stake by 202% in Q1 2026, buying an estimated $542K and bringing the position to 10,271 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.

Walleye Capital first reported a position in GEHC in Q1 2024 and has held it in 9 quarters since. The position peaked at $15.6M in Q3 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Walleye Capital held 10,271 shares of GE HealthCare worth $731K as of Q1 2026.
  • Walleye Capital bought 6,867 GE HealthCare shares in Q1 2026, an estimated $542K.
  • GE HealthCare made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2358 holding.
  • Walleye Capital first reported a position in GE HealthCare in Q1 2024 and has held it in 9 quarters since.
  • Walleye Capital's GE HealthCare position peaked at $15.6M in Q3 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.